Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
The fund's manager utilizes a passive investment strategy, aiming to closely mirror the returns of its target index. This benchmark is systematically constructed based on specific criteria, focusing on companies engaged in the legal development and application of psychedelic treatments for various medical conditions, adhering to the regulatory frameworks of the respective countries. Generally, the fund will acquire all of the index's constituent securities, maintaining portfolio weightings that approximate their representation within the index. It is important to note that this fund is non-diversified.
No one on the platform currently holds PSYK.
No tracked institution reports a position in PSYK as of their last filing.
No one on the platform has traded PSYK yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PSYKPSYK ETF | $16.48 | +0.30% | $2M | — |
| AMEREmles Made in America ETF | $26.18 | -0.08% | $2M | — |
| BCNAReality Shares Nasdaq NexGen Economy China ETF | $20.83 | +0.05% | $2M | — |
| ENRGSoFi Smart Energy ETF | $12.33 | -2.23% | $2M | — |
| FDCEFoundations Dynamic Core ETF | $12.61 | +0.00% | $2M | — |
| FLZAFranklin FTSE South Africa ETF | $19.57 | +0.00% | $2M | — |
| KMEDKraneShares Emerging Markets Healthcare Index ETF | $18.81 | -2.72% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
The fund adviser uses a “passive management” (or indexing) approach to track the performance of the index. The index is a rules-based index that tracks the performance of a portfolio of companies that have business activity in the fields of psychedelic treatment used to address medical conditions in legal pharmacological applications under the applicable country’s laws. The fund will generally invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.
No constituent disclosure available for this fund yet.
$PSYK $IBIT Exchange Traded Concepts to Close and Liquidate the PSYK ETF https://www.stocktitan.net/news/PSYK/exchange-traded-concepts-to-close-and-liquidate-the-psyk-b7b9ljtnwdyy.html
View on StockTwits ↗$PSYK Exchange Traded Concepts to Close and Liquidate the PSYK ETF https://newsfilter.io/a/b6eb809b7f485fc74a97986816e0fa0e
View on StockTwits ↗Peace from the Ghettos of Edmonton, Alberta $HAS $HD $PSYK $PM https://youtu.be/iHPFW6VcZQI
View on StockTwits ↗I’d love to work with Jaczek of $PM but he needs to reach out to me first. I’ve already discussed microdosing with him on Twitter but he can’t be reached for comment. $PSYK $WEED look very promising as does $HD honestly
View on StockTwits ↗$PSIL Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More $AWKNF , $CMND , $FLHLF , $MYCOF , $PSIL , $PSYGF , $PSYK , $RVVTF https://tradeui.com/news/30133941/psyched-first-ayahuasca-pill-created-psychedelics-legalization-predicted-uks-research-support-and-more
View on StockTwits ↗$PSIL Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More $AWKNF , $CMND , $CMPS , $PSIL , $PSYK https://tradeui.com/news/29884250/psyched-full-dose-and-microdosing-lsd-studies-research-scope-for-fed-funding-consumption-sites-and-more
View on StockTwits ↗$PSIL $HELP.DL0126 $PSY $PSYK $MYCOD "[Cybin] is pleased to announce that its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”) has completed dosing for four out of five participant cohorts and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues."
View on StockTwits ↗$SEEL apparently nobody takes notice. Good stuff. $CMPS $ATAI $PSYK “Seelos Therapeutics has been awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research to advance the development of its gene therapy candidate SLS-004 in people with Parkinson’s disease. SLS-004 aims to regulate the expression, or levels, of the SNCA gene, which provides instructions to produce alpha-synuclein, a key protein in the development of Parkinson’s disease. “The selection of SLS-004 to receive grant funding from The Michael J. Fox Foundation is a strong validation of our program and should significantly raise the profile of our program,”
View on StockTwits ↗$SEEL $HELP.DL0126 $PSYK $ATAI $CMPS “Seelos thanks @MicrodoseHQ #WonderlandMiami where we presented our open label data and plans developing SLS-002 (intranasal racemic ketamine) for imminent Suicidality in Major Depressive Disorder. Also, thank you to Dean @garwboy for moderating our talk. The media message below:”
View on StockTwits ↗$HELP.DL0126 $PSIL $PSYK $SEEL most all near all time lows.
View on StockTwits ↗$CMPS Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More $CMPS , $PSIL , $PSYK , $TSLA https://tradeui.com/news/29274249/psyched-vc-fund-invests-50m-in-psychedelics-musks-exploratory-journeys-native-american-use-of-peyote-and-more
View on StockTwits ↗$PSYK This isn't even on most people's radar - Breaking out
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.